According to Lifecore Biomedical's latest financial reports the company has $19.09 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-05-31 | $1.64 M | 41.76% |
2021-05-31 | $1.15 M | 221.94% |
2020-05-31 | $0.36 M | -66.67% |
2019-05-31 | $1.08 M | -62.75% |
2018-05-31 | $2.89 M | -51.67% |
2017-05-31 | $5.99 M | -39.38% |
2016-05-31 | $9.89 M | -29.96% |
2015-05-31 | $14.12 M | -0.81% |
2014-05-31 | $14.24 M | -6.68% |
2013-05-31 | $15.26 M | -31.18% |
2012-05-31 | $22.17 M | -38.84% |
2011-05-31 | $36.25 M | -24.83% |
2010-05-31 | $48.23 M | -26.86% |
2009-05-31 | $65.95 M | 11.72% |
2008-05-31 | $59.03 M | -5.62% |
2007-05-31 | $62.55 M | 312.53% |
2006-05-31 | $15.16 M | 2.19% |
2005-05-31 | $14.83 M | 129.78% |
2004-05-31 | $6.45 M | 74.59% |
2003-05-31 | $3.69 M | |
2002-10-31 | $7.84 M | -9.73% |
2001-10-31 | $8.69 M |